Search
Business Advisors
Frank Langley
Frank Langley is President & CEO of Addiction Therapeutix.
He has over twenty five years of commercialization experience in the formation, management, and exits of life sciences companies. His experience ranges from founder of start-up biotechnology companies to management in a Fortune 500 medical device company. In his last successful exit, he served as President & CEO of Pel-Freez Clinical Systems, where he led and managed the development and marketing of a new molecular biology product line for solid organ and bone marrow transplantation through a successful strategic company sale. He has undergraduate (BBA-University of Wisconsin) and graduate (MBA-College of St. Thomas) degrees in business administration and finance and is a graduate of Stanford University’s Advanced Technology Management Program. Mr. Langley is past President of the Wisconsin Biotechnology and Medical Device Association and has a number of past and current healthcare board appointments.
He has over twenty five years of commercialization experience in the formation, management, and exits of life sciences companies. His experience ranges from founder of start-up biotechnology companies to management in a Fortune 500 medical device company. In his last successful exit, he served as President & CEO of Pel-Freez Clinical Systems, where he led and managed the development and marketing of a new molecular biology product line for solid organ and bone marrow transplantation through a successful strategic company sale. He has undergraduate (BBA-University of Wisconsin) and graduate (MBA-College of St. Thomas) degrees in business administration and finance and is a graduate of Stanford University’s Advanced Technology Management Program. Mr. Langley is past President of the Wisconsin Biotechnology and Medical Device Association and has a number of past and current healthcare board appointments.